Phenotypic Measurements and Their Relation to Disease Exacerbation in COPD Patients

NCT03300739 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 20

Last updated 2020-09-30

No results posted yet for this study

Summary

This is an observational pilot study focused on collecting data on clinical variables that can improve the understanding of potential predictors of disease exacerbation and readmissions in COPD patients. The study aim is to understand how the variability of clinical parameters (respiratory rate, forced expiratory volume in one second, and oxygen saturation), physical activity and quality of life is associated with the risk of exacerbation in COPD patients.

Conditions

  • COPD Exacerbation
  • Copd

Sponsors & Collaborators

  • ResMed

    collaborator INDUSTRY
  • Massachusetts General Hospital

    lead OTHER

Principal Investigators

  • Stephen Agboola, MD · MGH

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-12-31
Primary Completion
2019-02-28
Completion
2019-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03300739 on ClinicalTrials.gov